Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agios Pharmaceuticals (AGIO) Gross Profit (2018 - 2025)

Historic Gross Profit for Agios Pharmaceuticals (AGIO) over the last 8 years, with Q3 2025 value amounting to $11.2 million.

  • Agios Pharmaceuticals' Gross Profit rose 3691.48% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.1 million, marking a year-over-year increase of 3296.46%. This contributed to the annual value of $32.3 million for FY2024, which is 3504.72% up from last year.
  • Agios Pharmaceuticals' Gross Profit amounted to $11.2 million in Q3 2025, which was up 3691.48% from $10.8 million recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Gross Profit high stood at $11.2 million for Q3 2025, and its period low was $493000.0 during Q1 2022.
  • Over the past 4 years, Agios Pharmaceuticals' median Gross Profit value was $6.8 million (recorded in 2023), while the average stood at $6.6 million.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Gross Profit skyrocketed by 92535.5% in 2023, and later skyrocketed by 104.47% in 2025.
  • Agios Pharmaceuticals' Gross Profit (Quarter) stood at $3.9 million in 2022, then skyrocketed by 67.23% to $6.5 million in 2023, then skyrocketed by 45.31% to $9.5 million in 2024, then increased by 18.28% to $11.2 million in 2025.
  • Its Gross Profit stands at $11.2 million for Q3 2025, versus $10.8 million for Q2 2025 and $7.6 million for Q1 2025.